Los Angeles Capital Management LLC Boosts Stock Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Los Angeles Capital Management LLC lifted its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 45.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 235,042 shares of the company’s stock after acquiring an additional 73,130 shares during the quarter. Los Angeles Capital Management LLC owned 0.09% of Ryan Specialty worth $15,080,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of the business. Signaturefd LLC increased its holdings in Ryan Specialty by 12.3% in the third quarter. Signaturefd LLC now owns 1,347 shares of the company’s stock valued at $89,000 after buying an additional 148 shares during the last quarter. Sanctuary Advisors LLC increased its holdings in Ryan Specialty by 1.2% in the fourth quarter. Sanctuary Advisors LLC now owns 15,690 shares of the company’s stock valued at $1,045,000 after buying an additional 188 shares during the last quarter. State of Alaska Department of Revenue increased its holdings in Ryan Specialty by 1.6% in the fourth quarter. State of Alaska Department of Revenue now owns 12,130 shares of the company’s stock valued at $778,000 after buying an additional 190 shares during the last quarter. CIBC Asset Management Inc increased its holdings in Ryan Specialty by 5.6% in the fourth quarter. CIBC Asset Management Inc now owns 3,674 shares of the company’s stock valued at $236,000 after buying an additional 196 shares during the last quarter. Finally, Loomis Sayles & Co. L P increased its holdings in Ryan Specialty by 26.3% in the third quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company’s stock valued at $91,000 after buying an additional 286 shares during the last quarter. Hedge funds and other institutional investors own 84.82% of the company’s stock.

Ryan Specialty Price Performance

Shares of RYAN opened at $68.97 on Wednesday. Ryan Specialty Holdings, Inc. has a fifty-two week low of $46.57 and a fifty-two week high of $75.97. The company has a market capitalization of $18.06 billion, a price-to-earnings ratio of 99.95, a price-to-earnings-growth ratio of 1.19 and a beta of 0.72. The firm has a 50-day simple moving average of $65.66 and a 200-day simple moving average of $67.34. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01.

Ryan Specialty (NYSE:RYAN) last announced its earnings results on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.02). Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The business had revenue of $663.53 million for the quarter, compared to analyst estimates of $658.80 million. On average, equities research analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th will be given a $0.12 dividend. The ex-dividend date of this dividend is Tuesday, March 4th. This represents a $0.48 dividend on an annualized basis and a yield of 0.70%. This is an increase from Ryan Specialty’s previous quarterly dividend of $0.11. Ryan Specialty’s dividend payout ratio (DPR) is presently 69.57%.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the company. Wells Fargo & Company increased their target price on Ryan Specialty from $64.00 to $69.00 and gave the company an “equal weight” rating in a report on Friday, February 21st. Royal Bank of Canada decreased their price objective on shares of Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating for the company in a research note on Friday, February 21st. Keefe, Bruyette & Woods decreased their price objective on shares of Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating for the company in a research note on Friday, February 21st. Barclays upped their price objective on shares of Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, November 21st. Finally, Morgan Stanley initiated coverage on shares of Ryan Specialty in a research note on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price objective for the company. One analyst has rated the stock with a sell rating, six have given a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $74.55.

Insider Activity at Ryan Specialty

In related news, Director Nicholas Dominic Cortezi sold 10,485 shares of the firm’s stock in a transaction dated Thursday, January 23rd. The shares were sold at an average price of $65.12, for a total value of $682,783.20. Following the completion of the sale, the director now owns 11,109 shares in the company, valued at $723,418.08. This trade represents a 48.56 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders sold a total of 316,451 shares of company stock worth $20,907,793 over the last 90 days. Company insiders own 11.10% of the company’s stock.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.